China SXT Pharmaceuticals plans 1-for-80 share consolidation effective Aug. 10
SXTC•1-for-80 reverse split effective Aug. 10
China SXT Pharmaceuticals will consolidate its Class A and Class B ordinary shares in a 1-for-80 reverse split effective Aug. 10, 2026.
- Class A shares are set to trade on a post-consolidation basis at the market open on Aug. 10 under SXTC; new CUSIP G2161P173.
- Class A shares outstanding are expected to fall to about 1,321,301 from 105,704,077; fractional shares will be rounded up.
- Outstanding stock options, warrants, and other purchase rights to Class A shares will be adjusted proportionately.
